Product Images Advair Diskus
View Photos of Packaging, Labels & Appearance
- Fluticasone propionate chemical structure - advair diskus spl graphic 01
- Salmeterol xinafoate chemical structure - advair diskus spl graphic 02
- Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 03
- S:\Project Files\A\Advair Diskus NDA 021077\Figures\advair-diskus-spl-graphic-04.jpg - advair diskus spl graphic 04
- Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 05
- Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 06
- Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 07
- Figure A - advair diskus spl graphic 08
- Figure B - advair diskus spl graphic 09
- Figure C - advair diskus spl graphic 10
- Figure D - advair diskus spl graphic 11
- Figure E - advair diskus spl graphic 12
- Figure F - advair diskus spl graphic 13
- Figure G - advair diskus spl graphic 14
- Figure H - advair diskus spl graphic 15
- Label Image - lbl500904505
Product Label Images
The following 16 images provide visual information about the product associated with Advair Diskus NDC 50090-4505 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 03

S:\Project Files\A\Advair Diskus NDA 021077\Figures\advair-diskus-spl-graphic-04.jpg - advair diskus spl graphic 04

Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 05

This text seems to mention the dosages and usage instructions for a medication called ADVAIR DISKUS 100D. It includes details such as the frequency of administration and the type of medication present in the diskus. The text also refers to parameters like "Change in FEV1", which could relate to pulmonary health monitoring.*
Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 06

Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 07

Figure A - advair diskus spl graphic 08

This is a list of parts for evaluating a product, possibly a tool or a device. It includes an outer case, a mouthpiece, and a thumb grip. These components are likely part of a larger item that requires them for functionality or usability.*
Label Image - lbl500904505

This text provides details on a medication product called Advair Diskus, an inhalation powder containing Fluticasone Propionate and Salmeterol Xinafoate. Each blister has 500 mcg of Fluticasone Propionate and 72.5 mg of Salmeterol Xinafoate. The product should be stored between 68 to 77 degrees Fahrenheit, away from heat and sunlight. The package includes one Diskus inhalation device containing a foil strip of 60 blisters. Distributed by AS Medication Solutions in Libertyville, IL. This product is for prescription use only. NDC: 50090-4505-0.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.